Đang chuẩn bị liên kết để tải về tài liệu:
Cost burden associated with advanced non-small cell lung cancer in Europe and influence of disease stage

Không đóng trình duyệt đến khi xuất hiện nút TẢI XUỐNG

Although evidence suggests that stage of disease may influence costs associated with non-small cell lung cancer (NSCLC), there remains a relative paucity of data on the financial burden incurred directly by patients and their informal caregivers as they progress through the disease course. | Cost burden associated with advanced non-small cell lung cancer in Europe and influence of disease stage

TÀI LIỆU LIÊN QUAN

Health-economic burden of dementia in South Korea

Investigating parents/caregivers financial burden of care for children with noncommunicable diseases in Ghana

The patient-level effect of the cost of Cancer care – financial burden in German Cancer patients

The cost of lost productivity due to premature cancer-related mortality: An economic measure of the cancer burden

Addressing obesity in the management of knee and hip osteoarthritis – weighing in from an economic perspective

The future costs of cancer attributable to excess body weight in Brazil, 2030-2040

Cost-effectiveness analysis of first and second-generation EGFR tyrosine kinase inhibitors as first line of treatment for patients with NSCLC harboring EGFR mutations

Báo cáo y học: "Treating patients with fibromyalgia in primary care settings under routine medical practice: a claim database cost and burden of illness study"

Báo cáo y học: " Morbidity and cost burden of methicillin-resistant Staphylococcus aureus in early onset ventilator-associated pneumonia"

Báo cáo y học: "Setting priorities for the health care sector in Zimbabwe using cost-effectiveness analysis and estimates of the burden of disease"
Đã phát hiện trình chặn quảng cáo AdBlock
Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.